Cargando…

Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA

INTRODUCTION: Healthcare workers (HCWs) are exposed to Mycobacterium tuberculosis (MTB) and therefore are screened for tuberculosis (TB). Results of TB screenings with the Interferon-γ Release Assay (IGRA) in a French psychiatric hospital without a TB ward are described. METHODS: At the Sainte-Anne...

Descripción completa

Detalles Bibliográficos
Autores principales: Nienhaus, Albert, Gariepy, Paul-Kenneth, Trouve, Catherine, Lhaumet, Christiane, Toureau, Jean, Peters, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094665/
https://www.ncbi.nlm.nih.gov/pubmed/25018775
http://dx.doi.org/10.1186/1745-6673-9-24
_version_ 1782325875742605312
author Nienhaus, Albert
Gariepy, Paul-Kenneth
Trouve, Catherine
Lhaumet, Christiane
Toureau, Jean
Peters, Claudia
author_facet Nienhaus, Albert
Gariepy, Paul-Kenneth
Trouve, Catherine
Lhaumet, Christiane
Toureau, Jean
Peters, Claudia
author_sort Nienhaus, Albert
collection PubMed
description INTRODUCTION: Healthcare workers (HCWs) are exposed to Mycobacterium tuberculosis (MTB) and therefore are screened for tuberculosis (TB). Results of TB screenings with the Interferon-γ Release Assay (IGRA) in a French psychiatric hospital without a TB ward are described. METHODS: At the Sainte-Anne Hospital, a referral centre for psychiatric patients throughout the municipal region of Paris, IGRA screening is performed during pre-employment and general health examination or after potential contact to MTB. The QuantiFERON Gold in tube (QFT) is used and data on TB history are assessed in a standardized manner. RESULTS: Between August 2008 und August 2013 in total 1.192 HCWs were tested and the QFT was positive in 265 (22.2%). Probability of a positive QFT increased with age. A second QFT was performed in 144 HCWs with a positive QFT and 53 (36.8%) HCWs had a reversion. With a positive QFT close to the cut-off (e.g. 0.35-0.7 IU/ml) the odds ratio for a reversion was 4.6 compared to an INF-γ concentration of ≥3.0 IU/ml. Probability of reversion was not influenced by preventive chemotherapy, which was completed by 28 (19.4%) HCWs with a positive QFT. No active TB was detected. CONCLUSION: Prevalence of positive IGRA is high in French HCWs as is the number of reversions in IGRA. Reversion rate is particularly high around the cut-off of the IGRA. A borderline zone will therefore reduce the influence of test variability.
format Online
Article
Text
id pubmed-4094665
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40946652014-07-13 Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA Nienhaus, Albert Gariepy, Paul-Kenneth Trouve, Catherine Lhaumet, Christiane Toureau, Jean Peters, Claudia J Occup Med Toxicol Research INTRODUCTION: Healthcare workers (HCWs) are exposed to Mycobacterium tuberculosis (MTB) and therefore are screened for tuberculosis (TB). Results of TB screenings with the Interferon-γ Release Assay (IGRA) in a French psychiatric hospital without a TB ward are described. METHODS: At the Sainte-Anne Hospital, a referral centre for psychiatric patients throughout the municipal region of Paris, IGRA screening is performed during pre-employment and general health examination or after potential contact to MTB. The QuantiFERON Gold in tube (QFT) is used and data on TB history are assessed in a standardized manner. RESULTS: Between August 2008 und August 2013 in total 1.192 HCWs were tested and the QFT was positive in 265 (22.2%). Probability of a positive QFT increased with age. A second QFT was performed in 144 HCWs with a positive QFT and 53 (36.8%) HCWs had a reversion. With a positive QFT close to the cut-off (e.g. 0.35-0.7 IU/ml) the odds ratio for a reversion was 4.6 compared to an INF-γ concentration of ≥3.0 IU/ml. Probability of reversion was not influenced by preventive chemotherapy, which was completed by 28 (19.4%) HCWs with a positive QFT. No active TB was detected. CONCLUSION: Prevalence of positive IGRA is high in French HCWs as is the number of reversions in IGRA. Reversion rate is particularly high around the cut-off of the IGRA. A borderline zone will therefore reduce the influence of test variability. BioMed Central 2014-07-08 /pmc/articles/PMC4094665/ /pubmed/25018775 http://dx.doi.org/10.1186/1745-6673-9-24 Text en Copyright © 2014 Nienhaus et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nienhaus, Albert
Gariepy, Paul-Kenneth
Trouve, Catherine
Lhaumet, Christiane
Toureau, Jean
Peters, Claudia
Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title_full Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title_fullStr Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title_full_unstemmed Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title_short Tuberculosis screening at the Sainte-Anne Hospital in Paris – results of first and second IGRA
title_sort tuberculosis screening at the sainte-anne hospital in paris – results of first and second igra
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094665/
https://www.ncbi.nlm.nih.gov/pubmed/25018775
http://dx.doi.org/10.1186/1745-6673-9-24
work_keys_str_mv AT nienhausalbert tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra
AT gariepypaulkenneth tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra
AT trouvecatherine tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra
AT lhaumetchristiane tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra
AT toureaujean tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra
AT petersclaudia tuberculosisscreeningatthesainteannehospitalinparisresultsoffirstandsecondigra